Tukiainen Eija, Kylänpää Marja-Leena, Puolakkainen Pauli, Kemppainen Esko, Halonen Kimmo, Orpana Arto, Methuen Taina, Salaspuro Mikko, Haapiainen Reijo, Repo Heikki
Second Department of Surgery, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
Pancreas. 2008 Jul;37(1):56-61. doi: 10.1097/MPA.0b013e31815d9bad.
Genotype assessment has been suggested to be a tool for predicting disease severity in acute pancreatitis (AP). To study this hypothesis, we performed genotype analysis of tumor necrosis factor (TNF) -308 A/G, CD14 -159C/T, and HSPA1B +1267 A/G polymorphisms.
This is a case-control association study of 397 patients with AP (214 of whom had an alcohol-induced AP) and 300 controls. The control group comprised 218 subjects with detailed data of alcohol consumption, 70 of whom were heavy drinkers (daily alcohol intake >40 g), and 92 blood donors. The severity of AP was determined according to the Atlanta classification. Genotyping was performed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-assisted genotyping method.
Major allele frequency in TNF gene was 0.87 for patients with AP and 0.86 for controls. For CD14, the gene major allele frequency was 0.60 for patients and 0.63 for controls. For HSPA1B, the major allele frequencies were 0.52 for patients and 0.49 for controls, respectively. The allele frequencies did not differ significantly between AP patients with organ failure and those with mild disease, patients with alcohol-induced AP, or those with biliary AP. The patients with septic infectious complications (n = 47) had genotype distribution no different from those with mild, uncomplicated disease (n = 245).
The TNF, CD14, and HSPA1B polymorphisms studied seem not to play a role in determining the severity of AP or the risk of alcohol-induced AP and thus do not serve as a tool for predicting disease severity.
基因型评估被认为是预测急性胰腺炎(AP)疾病严重程度的一种工具。为了研究这一假设,我们对肿瘤坏死因子(TNF)-308 A/G、CD14 -159C/T和热休克蛋白A1B(HSPA1B)+1267 A/G多态性进行了基因型分析。
这是一项病例对照关联研究,纳入了397例AP患者(其中214例为酒精性AP)和300例对照。对照组包括218例有详细饮酒数据的受试者,其中70例为重度饮酒者(每日酒精摄入量>40 g),以及92例献血者。AP的严重程度根据亚特兰大分类法确定。基因分型采用基质辅助激光解吸/电离飞行时间质谱辅助基因分型方法。
AP患者中TNF基因的主要等位基因频率为0.87,对照组为0.86。对于CD14,患者的基因主要等位基因频率为0.60,对照组为0.63。对于HSPA1B,主要等位基因频率患者组为0.52,对照组为0.49。器官衰竭的AP患者与轻症患者、酒精性AP患者或胆源性AP患者之间的等位基因频率无显著差异。有脓毒症感染并发症的患者(n = 47)的基因型分布与轻症、无并发症患者(n = 245)无异。
所研究的TNF、CD14和HSPA1B多态性似乎在决定AP的严重程度或酒精性AP风险方面不起作用,因此不能作为预测疾病严重程度的工具。